PubMed · 16423843
Directed evolution of RuBisCO hypermorphs through genetic selection in engineered E.coli.
Abstract
The Calvin Cycle is the primary conduit for the fixation of carbon dioxide into the biosphere; ribulose 1,5-bisphosphate carboxylase/oxygenase (RuBisCO) catalyzes the rate-limiting fixation step. Our goal is to direct the evolution of RuBisCO variants with improved kinetic and biophysical properties. The Calvin Cycle was partially reconstructed in Escherichia coli; the engineered strain requires the Synechococcus PCC6301 RuBisCO for growth in minimal media supplemented with a pentose. We randomly mutated the gene encoding the large subunit of RuBisCO (rbcL), co-expressed the resulting library with the small subunit (rbcS) and the Synechococcus PCC7492 phosphoribulokinase (prkA), and selected hypermorphic variants. The RuBisCO variants that evolved during three rounds of random mutagenesis and selection were over-expressed, and exhibited 5-fold improvement in specific activity relative to the wild-type enzyme. These results demonstrate a new strategy for the artificial selection of RuBisCO and other non-native metabolic enzymes.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Monal R Parikh, Dina N Greene, Kristen K Woods, Ichiro Matsumura. 2006-01-19. Directed evolution of RuBisCO hypermorphs through genetic selection in engineered E.coli.. https://doi.org/10.1093/protein%2Fgzj010. https://pubmed.health/record/pubmed%3A16423843/directed-evolution-of-rubisco-hypermorphs-through-genetic-selection-in-engineered-e-coli
Citations retain the original authors and DOI and include this site’s record URL. If this discovery service contributed to your research, you can also cite PubMed Health by Indiciae: BibTeX · RIS.